rss
J Clin Pathol 2005;58:839-844 doi:10.1136/jcp.2004.023853
  • Original article

Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: biological and clinical implications

  1. S L Kong1,
  2. M Salto-Tellez2,
  3. A P K Leong3,
  4. Y H Chan4,
  5. E S C Koay1
  1. 1Department of Pathology, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260
  2. 2Molecular Diagnosis Centre, Department of Laboratory Medicine, National University Hospital, Singapore 119074
  3. 3Department of Surgery, National University Hospital, Singapore
  4. 4Clinical Trials and Epidemiology Research Unit, 226 Outram Road, Singapore 169039
  1. Correspondence to:
 Dr E S C Koay
 Department of Pathology, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260; patkoayenus.edu.sg
  • Accepted 4 January 2005

Abstract

Aims: Nodal expression of the carcinoembryonic antigen (CEA), cytokeratin 20 (CK20), and guanylyl cyclase C (GCC) genes was measured in tandem in patients with colorectal cancer (CRC) to assess whether there would be sufficient agreement between these markers in their ability to detect micrometastasis to qualify one of them as a universal marker, and whether frozen and paraffin wax embedded tissues would yield similar results.

Methods: One hundred and seventy five frozen lymph nodes (FT) and 158 formalin fixed, paraffin wax embedded lymph nodes (PET) from 28 CRC cases were analysed using gene specific quantitative real time polymerase chain reaction, carried out on the LightCycler® system with SYBR Green chemistry.

Results: There was significant disparity in positive detection of the three biomarkers in FT versus PET, with notable agreement achieved only for CEA (66.6%) in FT versus PET in Dukes’ B disease, and between CK20 and GCC (44.6%) in FT, also in Dukes’ B disease. One patient with full concordance in all three tumour markers with both tissue types suffered a relapse and died within two years of follow up.

Conclusions: There was considerable discordance in the positive detection of the three tumour markers in both tissue types (FT versus PET). This brings into question whether using a single tumour marker to detect micrometastasis in one tissue type (FT or PET) is adequately representative, and challenges the concept of universal markers for molecular CRC metastatic detection. Multiple tumour markers would predict more accurately the metastatic potential of Dukes’ B CRCs.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.